相关实验视频

Updated: Jun 6, 2025

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

丧失CFHR5功能降低了与年龄相关的黄斑变性风险

Mary Pat Reeve^1,2,3, Stephanie Loomis⁴, Eija Nissilä⁵

¹Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.

medRxiv : the preprint server for health sciences

|November 28, 2024

概括

研究人员在CFH基因附近确定了与年龄相关的黄斑变性 (AMD) 的四种保护性遗传变异. CFHR5中的两个变异显著降低了FHR-5蛋白水平,这表明了AMD的新治疗点.

科学领域:

遗传学是一个遗传学.
免疫学免疫学免疫学
眼科医生眼科眼科

背景情况:

与年龄相关的黄斑变性 (AMD) 是老年人视力丧失的主要原因.
遗传因素,特别是靠近补充因子H (CFH) 基因的遗传因素,对AMD风险有很大影响.
目前对AMD的治疗选择有限.

研究的目的:

在CFH区域内识别与保护AMD相关的特定遗传变异.
研究已识别的变异对补充通路蛋白的功能影响.
探索针对FHR-5进行AMD治疗的治疗潜力.

主要方法:

进行了全基因组关联测试,统计微绘和条件分析.
使用了12495例AMD病例和461,686例对照的大量队列.
进行了FinnGen样本召回研究,以评估血清蛋白水平和补充通路活性.

主要成果:

确定了四种主要的CFH类型,它们可以提供对AMD的保护.
两种保护性单元类型归因于CFH调节器CFHR5.5的变体.
携带CFHR5变异的携带者显示FHR-5和相关蛋白质的血清水平降低,与补充通路活性相关.

结论:

CFHR5中的遗传变异通过调节FHR-5水平,在AMD保护中发挥重要作用.
降低FHR-5水平与维护补充通路活性有关.
对FHR-5的治疗性下调是预防或治疗AMD的一个有希望的策略.

更多相关视频

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

Enrichment of Bruch's Membrane from Human Donor Eyes

Enrichment of Bruch's Membrane from Human Donor Eyes

Published on: November 15, 2015

相关概念视频

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...